Literature DB >> 349258

[Comparative studies of growth hormone secretion in acromegaly after isolated and combined application of insulin hypoglycemia, LH-RH- and TRH tests (author's transl)].

K R Schneider, G Müller, W Wiegelmann, H G Solbach, H L Krüskemper.   

Abstract

Growth hormone (GH) release was measured in 17 patients with active acromegaly following the administration of insulin, LH-RH and TRH given intravenously either combined or each separately. The simultaneous application of insulin and the hypothalamic releasing hormones resulted in a striking increase of plasma GH in 15 out of 17 patients. Inappropriate stimulation of GH release was found in 9 out of the 17 patients with acromegaly, when TRH was given as the only hormone; conversely this phenomenon due to LH-RH application was observed in 4 cases. In insulin-induced hypoglycemia GH release could be stimulated in 5 patients. After selective, transsphenoidal hypophysectomy, 4 of 13 patients still showed a definite stimulation of GH release after the combined use of test substances. Two of these also exhibited a comparable stimulation of GH after TRH, indicating adenoma cells remaining active after operation. The combined insulin-induced hypoglycemia/LH-RH/TRH-test is therefore advisable for patients with acromegaly, since GH release as well as other hypophyseal partial functions can be tested. The performance of individual tests is essential for evaluating selective stimulation of GH release.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 349258     DOI: 10.1007/bf01477061

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  35 in total

1.  [A combined stimulation test for the simultaneous analysis of several partial functions of the anterior pituitary gland (author's transl)].

Authors:  H K Kley; W Wiegelmann; H G Solbach; H L Krüskemper
Journal:  Dtsch Med Wochenschr       Date:  1974-10-11       Impact factor: 0.628

2.  The application of synthetic LRF and TRF in a combined function test in patients with pituitary tumors.

Authors:  J Köbberling; E Halves; T Scharphuis
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1973

3.  Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.

Authors:  G Faglia; P Beck-Peccoz; C Ferrari; P Travaglini; B Ambrosi; A Spada
Journal:  J Clin Endocrinol Metab       Date:  1973-06       Impact factor: 5.958

4.  Radioimmunoassay of HGH, ICSH and FSH in plasma after i.v. addministration of thyrotropin releasing hormone (TRH).

Authors:  W Wiegelmann; W Wildmeister; F A Horster; H G Solbach
Journal:  Horm Metab Res       Date:  1972-11       Impact factor: 2.936

5.  Preliminary observations on the effect of synthetic thyrotropin releasing factor on plasma thyrotropin levels in man.

Authors:  N Fleischer; R Burgus; W Vale; T Dunn; R Guillemin
Journal:  J Clin Endocrinol Metab       Date:  1970-07       Impact factor: 5.958

6.  [Stimulation of growth hormone and prolactin secretion with TRH in acromegaly (author's transl)].

Authors:  K von Werder; R Fahlbusch; R Gay; C R Pickhardt; B Schultz
Journal:  Klin Wochenschr       Date:  1976-04-01

7.  Growth hormone release following thyrotrophin-releasing hormone injection into patients with anorexia nervosa.

Authors:  K Maeda; Y Kato; N Yamaguchi; K Chihara; S Ohgo
Journal:  Acta Endocrinol (Copenh)       Date:  1976-01

8.  Dynamic evaluation of growth hormone (GH) and prolactin (hPRL) secretion in active acromegaly with high and low GH output.

Authors:  G Tolis; L Kovacs; H Friesen; J B Martin
Journal:  Acta Endocrinol (Copenh)       Date:  1975-02

9.  [The diagnostic significance of synthetic LH-RH (luteinizing hormone-releasing hormone) in evaluating gonadotropic pituitary function (author's transl)].

Authors:  H G Solbach; W Wiegelmann; H K Kley; H Zimmermann; H L Krüskemper
Journal:  Dtsch Med Wochenschr       Date:  1973-11-09       Impact factor: 0.628

10.  Hypoglycemia: a potent stimulus to secretion of growth hormone.

Authors:  J ROTH; S M GLICK; R S YALOW
Journal:  Science       Date:  1963-05-31       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.